Atlas Trials

Safety and Efficacy Study of Donor Natural Killer Cells Given After Haploidentical Hematopoietic Cell Transplantation

Clinical trial NCT01795378 · COMPLETED

Trial details

NCT number
NCT01795378
Sponsor
Asan Medical Center
Status
COMPLETED
Phase
Phase 1, Phase 2
Study type
INTERVENTIONAL
Acute Myelogenous LeukemiaAcute Lymphoblastic Leukemia
Start date
2013-02-01
Primary completion
2015-05-01
Enrollment
56

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.